Qiagen (QGEN) P/E (2009 - 2026)
Qiagen (QGEN) P/E from Dec 31, 2009 to Jul 21, 2026. The TTM Qiagen (QGEN) P/E is 19.68. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Qiagen (QGEN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 19.68 | -14.38% |
| 2025 | 22.99 | -79.99% |
| 2024 | 114.92 | +407.81% |
| 2023 | 22.63 | +5.29% |
| 2022 | 21.49 | -10.27% |
| 2021 | 23.95 | -26.45% |
| 2020 | 32.57 | -118.29% |
| 2019 | -178.08 | -550.91% |
| 2018 | 39.49 | -52.85% |
| 2017 | 83.77 | +73.04% |
| 2016 | 48.41 | +1.34% |
| 2015 | 47.77 | +5.76% |
| 2014 | 45.17 | -41.86% |
| 2013 | 77.68 | +143.39% |
| 2012 | 31.92 | +42.47% |
| 2011 | 22.40 | -29.36% |
| 2010 | 31.71 | -12.45% |
| 2009 | 36.22 | N/A |
Comparison Qiagen (QGEN) P/E with competitors
Qiagen (QGEN) P/E is 19.68.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -94.67% |
| MBAI | CheckCap Ltd | 1.71 | -91.30% |
| FONR | Fonar Corp | 15.48 | -21.37% |
| DGX | Quest Diagnostics Inc | 22.47 | +14.17% |
| LH | Laboratory Corp Of America Holdings | 23.87 | +21.27% |
| IQV | IQVIA Holdings Inc | 25.28 | +28.44% |
| A | Agilent Technologies Inc | 26.96 | +36.95% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | +60.17% |
| MTD | Mettler-Toledo International Inc | 32.45 | +64.85% |
| MEDP | Medpace Holdings Inc | 32.55 | +65.35% |
| DHR | Danaher Corp | 38.55 | +95.85% |
| IDXX | Idexx Laboratories Inc | 40.58 | +106.12% |
| ILMN | Illumina Inc | 44.12 | +124.13% |
| RVTY | Revvity Inc | 52.68 | +167.62% |
| VCYT | Veracyte Inc | 53.71 | +172.86% |
| ICLR | Icon Plc | 57.45 | +191.85% |
| SHC | Sotera Health Company | 74.08 | +276.35% |
| WAT | Waters Corp | 102.79 | +422.15% |